Pharmaceuticals, Biotechnology and Life Sciences
Boehringer Ingelheim focuses on the development of next generation NASH treatments that target all three key drivers of the disease…
– Martin Edwards, MD, Elected as Chair – – Chair Richard H. Aldrich Resigns in Planned Transition – CAMBRIDGE, Mass.…
Phase I results provide additional clinical activity data for Bicycles CAMBRIDGE, U.K., & BOSTON–(BUSINESS WIRE)–Bicycle Therapeutics, a biotechnology company pioneering…
LONDON–(BUSINESS WIRE)–#Research–The global neuroendocrine tumors therapeutics market is highly concentrated. Because of the high investment required for drug development and…
GAITHERSBURG, Md.–(BUSINESS WIRE)–Viela Bio today announced the appointment of Mitchell Chan as Chief Financial Officer, effective July 1. In this…
Created by Versant Ventures and partnered with Fujifilm to develop iPSC-derived adaptive and innate immune effector cell therapies Leaps by…
New leader to rapidly build team and capabilities to scale unique stem cell-derived platelet manufacturing platform, advance core program to…
LONDON–(BUSINESS WIRE)–#Research–The emergence of targeted therapies for the treatment of bone cancer is expected to drive market growth. Currently, targeted…
KENILWORTH, N.J.–(BUSINESS WIRE)–$MRK #MRK–Merck (NYSE:MRK), known as MSD outside the United States and Canada, will hold its second-quarter 2019 sales…
NEW YORK–(BUSINESS WIRE)–$BMY—Bristol-Myers Squibb Company (NYSE:BMY) announced today that effective July 1, 2019 it has completed its previously announced divestment…